SCHEMBL2424072

SCHEMBL2424072

Cc1cc(C(N)=O)c(NC(C)C(C)C)cc1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 3/20 0.42
HSP90AA1 P07900 5/20 0.36
HSP90AB1 P08238 5/20 0.36
NNMT P40261 2/20 0.36
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35
GABRA4 P48169 1/20 0.35
GABRE P78334 1/20 0.35
GABRA6 Q16445 1/20 0.35
GABRG1 Q8N1C3 1/20 0.35
GABRG3 Q99928 1/20 0.35
GABRQ Q9UN88 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2424070 1.00 HCAR3 (0.42) HCAR3HSP90AA1HSP90AB1NNMTGABRP
SCHEMBL2424707 0.91 HSP90AA1 (0.41) HCAR3HSP90AA1HSP90AB1NNMTGABRP
SCHEMBL2430012 0.88 HSP90AA1 (0.35) HCAR3HSP90AA1HSP90AB1NNMTGABRP
SCHEMBL2423473 0.88 GRM1 (0.38) HSP90AA1HSP90AB1NNMTGABRPGABRD
SCHEMBL2425814 0.85 JAK2 (0.38) HSP90AA1HSP90AB1NNMTGABRPGABRD
SCHEMBL2425812 0.85 JAK2 (0.38) HSP90AA1HSP90AB1NNMTGABRPGABRD
SCHEMBL2425735 0.84 CA1 (0.41) HCAR3KDM4EGAAALDH1A1GLA
SCHEMBL2423486 0.84 CA1 (0.41) HCAR3KDM4EGAAALDH1A1GLA
SCHEMBL13450924 0.84 CA1 (0.41) HCAR3KDM4EGAAALDH1A1GLA
SCHEMBL2424142 0.84 HSP90AA1 (0.46) HCAR3HSP90AA1HSP90AB1NNMTGABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 US disclosed
EP-2074120-B1 TROPANE COMPOUNDS EXELIXIS INC (US) 2010-03-03 EP disclosed
EP-2074120-A1 TROPANE COMPOUNDS Exelixis, Inc. (US) 2009-07-01 EP disclosed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 US disclosed
WO-2009055077-A1 TROPANE COMPOUNDS EXELIXIS, INC. (US) 2009-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163471-A1 Tropane compounds ADRA1B, ADRA2B, ADRB2 HCAR3 1036/4885HSP90AA1 1888/4885HSP90AB1 1352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.